ConductScience.org, home

Paper6608052

Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial.

CASS Principal Investigators and Their Associates. N Engl J Med, 1984. Cited by 245 papers, by iCite.

Cite this record

ConductScience Library. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. Papers, record 6608052. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6608052

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial.
PubMed
Journal
N Engl J Med
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
245
iCite
Relative citation ratio, by iCite
7.18
iCite
Revised in PubMed
2022-03-31
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1CASS Principal Investigators and Their AssociatesGroup

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary Artery BypassMajor topic
Myocardial InfarctionMajor topic
Angina Pectoris
Electrocardiography
Female
Humans
Male
Middle Aged
Probability
Random Allocation

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00000489Coronary Artery Surgery Study (CASS)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 245 citations.

PMIDTitleJournalYearIn PapersSource
35653055Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?Curr Cardiol Rep2022https://conductscience.org/library/papers/35653055PubMed
33267610Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.Circulation2021https://conductscience.org/library/papers/33267610PubMed
31787055Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster Registry.J Am Heart Assoc2019https://conductscience.org/library/papers/31787055PubMed
30647744Coronary endarterectomy: an old tool for patients currently operated on with coronary artery bypass grafting. Long-term results, risk factor analysis.Kardiochir Torakochirurgia Pol2018https://conductscience.org/library/papers/30647744PubMed
29114176Detecting Triple-Vessel Disease with Cadmium Zinc Telluride-Based Single-Photon Emission Computed Tomography Using the Intensity Signal-to-Noise Ratio between Rest and Stress Studies.Contrast Media Mol Imaging2017https://conductscience.org/library/papers/29114176PubMed
25708977Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease.Curr Treat Options Cardiovasc Med2015https://conductscience.org/library/papers/25708977PubMed
23621905
A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL₃+IDL]).
Lipids Health Dis2013https://conductscience.org/library/papers/23621905PubMed
23304036Will stent revascularization replace coronary artery bypass grafting?Tex Heart Inst J2012https://conductscience.org/library/papers/23304036PubMed
22980305Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.Am Heart J2012https://conductscience.org/library/papers/22980305PubMed
22555943Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.Curr Cardiol Rep2012https://conductscience.org/library/papers/22555943PubMed
18805103Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.Am J Cardiol2008https://conductscience.org/library/papers/18805103PubMed
18373326Trials and tribulations associated with angina and traditional therapeutic approaches.Clin Cardiol2007https://conductscience.org/library/papers/18373326PubMed
18001623Evidence-based treatment of unprotected left main disease: a critical review of the literature.Curr Atheroscler Rep2007https://conductscience.org/library/papers/18001623PubMed
17726321Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.Cardiology2008https://conductscience.org/library/papers/17726321PubMed
17550580Skeletonization of radial and gastroepiploic conduits in coronary artery bypass surgery.J Cardiothorac Surg2007https://conductscience.org/library/papers/17550580PubMed
17174803Revascularize only for ischemia, especially if left ventricular function is poor.J Nucl Cardiol2006https://conductscience.org/library/papers/17174803PubMed
16822360Revascularization for patients with severe coronary artery disease and left ventricular dysfunction.Curr Cardiol Rep2006https://conductscience.org/library/papers/16822360PubMed
16822359Surgical, medical, and percutaneous therapies for patients with multivessel coronary artery disease.Curr Cardiol Rep2006https://conductscience.org/library/papers/16822359PubMed
15720299Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints.Ann Hum Genet2005https://conductscience.org/library/papers/15720299PubMed
15610328Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.J Gen Intern Med2004https://conductscience.org/library/papers/15610328PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6608052

GET https://conductscience.org/api/papers/v1/6608052/cited_by?page=2